While reporting financial results for the fourth quarter on Thursday, medical technology company Integra LifeSciences Holdings Corp. (IART) initiated adjusted earnings and revenue guidance for the full-year 2021 and for the first quarter.
For fiscal 2021, the company now projects adjusted earnings in a range of $2.86 to $2.93 per share on revenues between $1.520 billion and $1.535 billion, with organic revenue growth of 12 to 13 percent.
On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.92 per share on revenues of $1.54 billion for the year. Analysts' estimates typically exclude special items.
For the first quarter, the company expects adjusted earnings in a range of $0.54 to $0.58 per share on revenues between $345 million and $355 million, with organic revenue growth of flat to 3 percent.
The Street is looking for earnings of $0.64 per share on revenues of $359.90 million for the quarter.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.